[Immunity and the stage of carcinogenesis progression (experimental bases of the concept)].
Mikhaĭlenko
A A
AA
Katul'skiĭ
Iu N
IuN
Denisov
V L
VL
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D004338:Drug Combinations; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008715:Methionine / Q000008:administration & dosage; D009374:Neoplasms, Experimental / Q000209:etiology / Q000276:immunology* / Q000517:prevention & control; D009696:Nucleic Acids / Q000008:administration & dosage; D010396:Penicillamine / Q000008:administration & dosage; D011736:Pyridoxine / Q000008:administration & dosage; D051381:Rats; D014815:Vitamins / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D009696:Nucleic Acids; D014815:Vitamins; C012866:decamevit; C013683:sodium nucleinate; D008715:Methionine; D010396:Penicillamine; D011736:Pyridoxine
Immunitet i stadiia progressa kantserogeneza (éksperimental'noe obosnovanie kontseptsii).